[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lenz et al., 2010 - Google Patents

Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts

Lenz et al., 2010

View HTML
Document ID
9711170793467349769
Author
Lenz A
Bennett M
Skelton W
Vesely D
Publication year
Publication venue
Pediatric research

External Links

Snippet

C-natriuretic peptide (CNP) has been shown to regulate proliferation of mouse and rat osteoblasts. Genetic deletion of CNP results in dwarfism. Overexposure of CNP has been associated with arachnodactyly of hands and feet with a very long hallux bilaterally in a 14-y …
Continue reading at www.nature.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Similar Documents

Publication Publication Date Title
Hadjidakis et al. Bone remodeling
Hallett et al. Growth plate chondrocytes: Skeletal development, growth and beyond
Battafarano et al. Bone control of muscle function
Le Roith et al. What is the role of circulating IGF-I?
Goltzman et al. The calcium-sensing receptor in bone—mechanistic and therapeutic insights
Guntur et al. Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass
Shore et al. Inherited human diseases of heterotopic bone formation
Capiati et al. 1, 25 (OH) 2‐vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells
Ceglia Vitamin D and its role in skeletal muscle
Hinuma et al. A prolactin-releasing peptide in the brain
Wang et al. Autocrine and paracrine actions of IGF-I signaling in skeletal development
Kim et al. Bone morphogenetic protein 4 supports the initial differentiation of hen (Gallus gallus) granulosa cells
Merlo et al. Growth, differentiation and survival of HC11 mammary epithelial cells: diverse effects of receptor tyrosine kinase-activating peptide growth factors.
Van Wyk et al. Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions
De Paula et al. Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling
Kumar New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia
Rodríguez-Alonso et al. Spatial and pregnancy-related changes in the protein, amino acid, and carbohydrate composition of bovine oviduct fluid
Wu et al. Bone morphogenetic protein 2 regulates cell–cell communication by down-regulating connexin43 expression in luteinized human granulosa cells
Pajevic et al. Osteocyte biology and space flight
Lenz et al. Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts
Park et al. Maternal vitamin D biomarkers are associated with maternal and fetal bone turnover among pregnant women consuming controlled amounts of vitamin D, calcium, and phosphorus
Pierroz et al. β‐Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice
Clemens et al. Genetic strategies for elucidating insulin-like growth factor action in bone
Bisello et al. Parathyroid hormone-related protein: an essential physiological regulator of adult bone mass
Mohan et al. IGF system components and their role in bone metabolism